Mumbai University to start courses in management, biotechnology ... Daily Bhaskar Mumbai University will start courses in management, biotechnology, nanotechnology and food processing in Thane campus, which will be operational by 2014. Rs11 crore has been sanctioned for the Thane sub-centre and the state plans to build ...

Source:
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNGa8N9vlbF7qKyQoSGAhZAa7f126Q&url=http://daily.bhaskar.com/article/EDU-mumbai-university-to-start-courses-in-management-biotechnology-nanotechnology-an-4227170-NOR.html

Manufacturing.net

BIL Gates And The BioBrick Foundation: A New Paradigm For Biotechnology? Manufacturing.net No, that's not a typo in the headline. I'm not talking about the founder of Microsoft, though he is no doubt the reason that biotechnology researcher Drew Endy decided to name his new computer-in-a-cell devices Boolean Integrase Logic gates (BIL for ...

Source:
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNH391kJ7rl00muH7rMGohZkosbzJA&url=http://www.manufacturing.net/articles/2013/04/bil-gates-and-the-biobrick-foundation-a-new-paradigm-for-biotechnology

Roger Ebert and Evolution - What Does the DNA Tell Us? Huffington Post (blog) In his original critique of a pro-ID film called eXpelled, Ebert combined an astute critique of creationist tactics with an exaggerated statement about Darwin's accomplishment and the fate of Darwinism in the days of molecular genetics and genome ... and more »

Source:
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNG57shoRnHZtgZfpF1ba4PDPUWgww&url=http://www.huffingtonpost.com/james-a-shapiro/roger-ebert-evolution_b_3021641.html

Haaretz

Israeli researchers find food supplement can help fight Parkinson's disease Haaretz Gil Ast of the university's Department of Human Molecular Genetics and Biochemistry has discovered that the supplement, known as phosphatidylserine, improves the function of genes involved in disorders such as familial dysautonomia Parkinson's disease. and more »

Source:
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNE3YUt9HujUBE9R4rNvuGybcq0Jtw&url=http://www.haaretz.com/news/national/israeli-researchers-find-food-supplement-can-help-fight-parkinson-s-disease.premium-1.513353

The Nation

Call to equip youth with IT education The Nation He was delivering lecture on opportunities for Pakistani scientists in the field of medicine at the concluding session of conference organized by Department of Microbiology and Molecular Genetics. Prof Shahida Hasnain, Vice Chancellor, Women University ...

Source:
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNHqVgQKN8OWpwAh0uc1jn6UhMuvHA&url=http://www.nation.com.pk/pakistan-news-newspaper-daily-english-online/lahore/06-Apr-2013/call-to-equip-youth-with-it-education

National Melanoma Summit media release: More public awareness of changing ... New Zealand Doctor Online He says recently there have been remarkable results in treating advanced melanoma with targeted therapies based on molecular genetics - pills designed with knowledge derived from the molecular genetics revolution. "They work so well that people who are ... and more »

Source:
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNG8W_1C0omSnsfx_Y4-xCHavewNng&url=http://www.nzdoctor.co.nz/un-doctored/2013/april-2013/05/national-melanoma-summit-media-release-more-public-awareness-of-changing-moles-needed.aspx

“Patient experience with BRCA1/2 genetic testing: a thematic analysis of free ... IUPUI Newscenter April Hall, Genetics Counseling Graduate Student, Division of Clinical and Biochemical Genetics, Department of Medical and Molecular Genetics, IU School of Medicine, will present, "Patient experience with BRCA1/2 genetic testing: a thematic analysis of ...

Source:
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNFReaW_JvKKfzzAR_l9bM2X25KVZA&url=http://events.iupui.edu/event/?event_id%3D8613

Wall Street Journal

Tough Calls on Prenatal Tests Wall Street Journal But there is a risk that aggressive marketing based on test performance from the early clinical trials could confuse physicians and patients with complex information, said Girish Putcha, a practicing molecular-genetics pathologist and former laboratory ... and more »

Source:
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNGFm08Zo3HgM5a2iQ0uZjABgUKw2g&url=http://online.wsj.com/article/SB10001424127887324883604578398791568615644.html

Natural History Magazine

Another Tenderfoot Natural History Magazine With the tools of molecular genetics at our disposal, even the most common birds can reveal fascinating secrets. Since my first trip in early 2011, I have traveled to New Guinea four times. When I returned from my last trip, my fieldwork completed, I ...

Source:
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNFjnkrVpKOplLqcBvWHtOlE1D7s3g&url=http://www.naturalhistorymag.com/endpaper/012456/another-tenderfoot

Examiner.com

Genetic instabilities a potential culprit for autism Examiner.com The study will be published in full in the upcoming edition of Human Molecular Genetics. According to the study, these genetic changes are caused by an overflow of DNA segments in hot spot areas, potentially affecting the possibility of a child ... and more »

Source:
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNHzNNCWVfFKnrkBnHiddnrI4LVHrg&url=http://www.examiner.com/article/genetic-instabilities-a-potential-culprit-for-autism

When does a financially struggling
biotech company turn down a $20 million “forgivable loan?”

“The funding would have been in the
form of a forgivable loan, however, we have elected not to borrow
these funds from CIRM(the stem cell agency).”

“You may also recall that last
September, CIRM approved a separate application under the same
disease team program for Alzheimer's disease, which was also for up
to $20 million in the form of a loan. We remain in confidential
negotiations with CIRM regarding the terms and conditions that would
attach to this loan.”

Nakae: “Okay. Just 2 more questions.
I guess the first one, as it relates to CIRM.
In deciding to decline the funding for spinal cord yet continuing to
pursue the funding for Alzheimer's, is there a difference in what
you're getting from them in terms of potential terms and conditions
that allow you to proceed on one and not the other, or is it the fact
that you're already in human with -- in spine, and still very
preclinical with Alzheimer's?”

McGlynn: :”I think you're very
definitely -- you're getting at some important criteria when one
considers how to fund programs whether you use debt or equity,
etcetera. So I wouldn't disagree with anything that you've outlined
or surmised. But I just would pray your indulgence until we're
finished, the negotiations with CIRM, which are coming to a close and
we expect those to resolve pretty quickly with regards to the
Alzheimer's program. And then quite frankly, we can be way more
forthcoming and way more disclosive with regards not only to our
decisions, but to our thinking.”

Source:
http://feedproxy.google.com/~r/blogspot/uqpFc/~3/zYvykN1XE6k/stemcells-inc-rejects-20-million-from.html

Stem Cell Therapy for Pets - Teddy Before After

By: NewmanVets

Read the rest here:
Stem Cell Therapy for Pets - Teddy Before

Stem Cell Therapy for Pets -- Taylor Before After

By: NewmanVets

Read more:
Stem Cell Therapy for Pets -- Taylor Before

Stem Cell Therapy Treatment for Duchenne Muscular Dystrophy by Dr Alok Sharma, Mumbai, India.
Stem Cell Therapy Treatment for Duchenne Muscular Dystrophy by Dr Alok Sharma, Mumbai, India. After Stem Cell Therapy PT assessment: 1) In walking, whole foo...

By: neurogenbsi

Originally posted here:
Stem Cell Therapy Treatment for Duchenne Muscular Dystrophy by Dr Alok Sharma, Mumbai, India. - Video

Stem cell therapy for AVN in India, Experience of patient from Canada
Avascular necrosis also known as osteonecrosis, aseptic necrosis, and ischemic bone necrosis. It is a disease resulting from the temporary or permanent loss ...

By: StemRx BioScience

Read more here:
Stem cell therapy for AVN in India, Experience of patient from Canada - Video

Stem Cell Therapy Treatment for Muscular Dystrophy by Dr Alok Sharma, Mumbai, India.
Stem Cell Therapy Treatment for Muscular Dystrophy by Dr Alok Sharma, Mumbai, India. After Stem Cell Therapy 1. Could stand with calipers and walker (after 7...

By: neurogenbsi

Read this article:
Stem Cell Therapy Treatment for Muscular Dystrophy by Dr Alok Sharma, Mumbai, India. - Video

Stem Cell Therapy Treatment Improvements in Muscular Dystrophy by Dr Alok Sharma, Mumbai, India.
Stem Cell Therapy Treatment Improvements in Muscular Dystrophy by Dr Alok Sharma, Mumbai, India. After Stem Cell Therapy 1. Could stand with calipers and wal...

By: neurogenbsi

Follow this link:
Stem Cell Therapy Treatment Improvements in Muscular Dystrophy by Dr Alok Sharma, Mumbai, India. - Video

Stem Cell Therapy Treatment for Spinal Cord Injury by Dr Alok Sharma, Mumbai, India.
Stem Cell Therapy Treatment for Spinal Cord Injury by Dr Alok Sharma, Mumbai, India. After Stem Cell Therapy 1. Ankle clonus/jerk in both legs has reduced. P...

By: neurogenbsi

Link:
Stem Cell Therapy Treatment for Spinal Cord Injury by Dr Alok Sharma, Mumbai, India. - Video

Stem Cell Therapy Treatment for Cerebral Palsy by Dr Alok Sharma, Mumbai, India.
Stem Cell Therapy Treatment for Cerebral Palsy by Dr Alok Sharma, Mumbai, India. After Stem Cell Therapy PT assessment: 1) Speech has improved. Now he is abl...

By: neurogenbsi

See original here:
Stem Cell Therapy Treatment for Cerebral Palsy by Dr Alok Sharma, Mumbai, India. - Video

ARAD, Israel, April 2, 2013 /PRNewswire/ --

Andain Inc. (ANDN) ("Andain" or the "Company"), a company engaged in commercializing novel technologies in biotech, medical and life sciences fields through its incubator program, today discussed and provided an update on its breakthrough, innovative stem cell therapy for treating and regenerating severely damaged muscle tissue.

Andain's innovative stem cell therapy technology rehabilitates and heals damaged muscle tissue by initiating regenerative myogenic cells (cardiac muscle), as well as striated muscle cells (skeletal muscle) growth in damaged tissue sites such as the myocardium (cardiac muscle) following an myocardial infarction (heart attack), limb pressure ulcers, and degenerative muscular diseases. The short term application is directed towards the treatment of patients with peripheral vascular disease, while the long term application is focused on the healing and regeneration of cardiac muscle following acute myocardial infarction or chronic heart failure.

Employing a patient's own cells (autologic transplantation), the Company's unique technology and process diverts the patient's own cells into specific targeted myogenic cells, which can then be inserted into the damaged tissue and accelerates the healing process. The administered myogenic or skeletal stem cells work as a network, acting in exactly the same way that the cells of skeletal and heart muscle tissue perform, and actually replenish the existing cells, thus strengthening the intended injured site following the transplantation process. This process can be utilized for different clinical pathologies as mentioned above and can also be utilized for patient using different donor as the source of the stem cells.

Our developed technology and protocols results in a promising safe regenerative therapy, without side effects, tissue rejection or the requirement of suppressive immunological treatment or malignant tumor hazard. Our technology also provides a simple, fast and safe treatment, overcoming technological difficulties associated with using other stem cell therapies sources such as embryonic, placenta, or umbilical cord blood cells that require cryogenic storage.

Andain's President and CEO Sam Elimelech, commented, "The field of stem cell therapeutics is in its early stages of growth as companies and researchers continue to uncover the vast potential and promising uses for them in the treatment and prevention of countless tissue injuries and diseases. We are in an excellent position to capitalize on the emergence of this new market. It is our belief that Orcell's cutting-edge technology and process is unique in regard to the fact that it allows for the safe and efficient directing of the patients own cells as into myogenic cells or striated muscle cells, thus eliminating the hazards associated with rejection and malignant tumors. Via our industrial incubator platform and expert scientific team, we look forward to helping Orcell commence their clinical trials later this year and make considerable progress of their technology and process closer to market."

Andain's incubator platform is currently undergoing with its stem cell technology a build-up of GLP (Good Laboratory Practice) production line as a preparation for the FDA approval stage with clinical trials scheduled for Q1 2014 at one of the foremost Heart centers in Israel under the direction of Professor Mickey Scheinowitz, one of Israel's leading scientists who gained vast experience in the understanding and treating of cardiovascular diseases.

ABOUT ANDAIN INC

Established in 2004 as a Nevada corporation with locations in Israel and the US, Andain (OTC: ANDN) commercializes novel technologies in the biotech, medical and life sciences fields, specializing in identifying technical innovations and providing a unique incubator/accelerator development and industrial platform. The company also offers technical know-how and business strategy expertise to commercialize new technologies and deliver shareholder value. For more information, please visit our website at http://www.andaininc.com.

FORWARD LOOKING STATEMENTS

Here is the original post:
Andain Inc. Discusses and Provides Update on its Breakthrough Stem Cell Therapy for the Treatment and Regeneration of ...